Biogen Inc.Long
$BIIB - long, wait for better entry close to $280, target $300+
BIIB - long, better entry at $280, earnings soon 1/30, 1st target mid line of parallel channel around $300
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.